Major study suggests beta-blockers for heart health could reduce violent crime
In a study involving more than 1.4 million people, Swedish and British scientists uncovered an association between treatments with beta blockers and a reduction in violent crime. (Source: the Mail online | Health)
Source: the Mail online | Health - February 1, 2023 Category: Consumer Health News Source Type: news

Preop Beta-Blockers and Stroke in Major Abdominal Surgery Preop Beta-Blockers and Stroke in Major Abdominal Surgery
Perioperative beta-blockade is sometimes used to reduce the risk of major adverse cardiac events for patients undergoing major noncardiac surgery. Does this increase the risk of stroke?Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2023 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Is This Primary Exertional Headache?
Discussion Commonly occurring primary headaches include tension, cluster and migraine headaches. “Other primary headaches” are often situational. Patients can have more than 1 type of these “other” headaches along with more common headaches. Other primary headaches as a group tend to be self-limited with long remission periods. Some other primary headaches include: Thunderclap headache Explosive sudden onset with maximum intensity in less 1 minute and resolution within 5 minutes usually 43/100,000 persons in adults Primary or secondary Secondary causes include intracranial hemorrhage, stroke, thro...
Source: PediatricEducation.org - November 21, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Late-Breaking Data from Pivotal Phase 3 PRECISION Study Demonstrates Significant and Sustained Effect of Aprocitentan on Lowering Blood Pressure for Patients with Difficult-to-Control Hypertension
RARITAN, NJ, November 7, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Idorsia Ltd, today announced results from the Phase 3 PRECISION study, which found aprocitentan, an investigational, novel dual endothelin receptor antagonist (ERA), significantly reduced blood pressure (BP) and maintained the effect for up to 48 weeks when added to standardized combination background antihypertensive therapy in patients with difficult-to-control hypertension (sometimes referred to as resistant hypertension). These data were presented as a Late-Breaking Science presentation during the Amer...
Source: Johnson and Johnson - November 7, 2022 Category: Pharmaceuticals Source Type: news

New Update Focuses on Acute Kidney Injury Management in Cirrhosis New Update Focuses on Acute Kidney Injury Management in Cirrhosis
Prevent volume loss, manage risk factors, hold beta blockers, and stop NSAIDs are among the key recommendations in a new update to prevent acute kidney injury in patients with cirrhosis.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 27, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

' Amazing' Data for Cheap Beta-Blocker Gel for Diabetic Foot Ulcers'Amazing' Data for Cheap Beta-Blocker Gel for Diabetic Foot Ulcers
Esmolol, a widely available and cheap beta-blocker, shows statistically significant superiority over the standard of care for diabetic foot ulcers, according to new, ' potentially game-changing ' phase 3 data.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 21, 2022 Category: Dermatology Tags: Diabetes & Endocrinology News Source Type: news

Are beta blockers past their sell-by date?
The latest NHS guidelines state that instead of beta blockers, most patients should be offered ACE inhibitors or, if these cause side effects, ARBs. Both work by relaxing blood vessels.. (Source: the Mail online | Health)
Source: the Mail online | Health - September 3, 2022 Category: Consumer Health News Source Type: news

ARBs, Beta-Blockers Inhibit Marfan Progression Independently ARBs, Beta-Blockers Inhibit Marfan Progression Independently
New data from the Marfan Treatment Trialists suggest effects of the two agents could be additive and that early treatment could potentially delay the need for surgery.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 31, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

Nonselective Beta-Blockers May Improve Outcomes in Ovarian Cancer
(MedPage Today) -- Women with cardiovascular conditions (CVCs) and ovarian cancer had better 2-year survival if they received a nonselective beta blocker (NSBB) at or around the time of cancer surgery, a review of medical records showed. Two-year... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 30, 2022 Category: Hematology Source Type: news

High Blood Pressure and Diabetes Are Linked. Here ’ s How to Reduce Your Risk for Both
High blood pressure—also known as hypertension—and Type 2 diabetes are two of the most common medical conditions in the U.S. Unfortunately, they often occur together. Some research has found that 85% of middle-aged or older adults who have Type 2 diabetes also have hyper­tension, and both conditions elevate a person’s risk for heart disease, stroke, and kidney disease. These increased risks are significant, and in some cases grave. Researchers have found that people with Type 2 ­diabetes are up to four times more likely to develop cardiovascular disease than those who don’t have the conditio...
Source: TIME: Health - August 29, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news

Doubling Up on Heart Drugs May Delay Aortic Damage From Marfan Syndrome
(MedPage Today) -- BARCELONA -- Angiotensin receptor blockers (ARBs) and beta-blockers both reduced expansion of the aortic root in patients with Marfan syndrome, according to a meta-analysis, suggesting a likely benefit from combination therapy... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 29, 2022 Category: Cardiology Source Type: news

Hot Weather MI Risk Hinted for Antiplatelets, Beta Blockers Hot Weather MI Risk Hinted for Antiplatelets, Beta Blockers
Why taking either drug class would promote nonfatal MIs on high-temperature days, or why it may have appeared that way, isn ' t clear, but researchers still urge caution for patients on these drugs.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - August 4, 2022 Category: Internal Medicine Tags: Cardiology News Source Type: news

Two heart medications tied to greater heart-attack risk in very hot weather
A new Yale study find beta-blockers, aspirin, and other antiplatelet medications to be associated with higher risk of heart attacks during very hot weather. (Source: Yale Science and Health News)
Source: Yale Science and Health News - August 1, 2022 Category: Universities & Medical Training Source Type: news

Beta Blockers Plus Checkpoint Inhibitor Improve Cancer Control Beta Blockers Plus Checkpoint Inhibitor Improve Cancer Control
Patients with urothelial carcinoma demonstrated improved overall survival as well. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Beta Blockers May Avert Cancer-Drug Cardiotoxicity Beta Blockers May Avert Cancer-Drug Cardiotoxicity
Treatment with some beta blockers may protect cardiac contractile function during anthracycline or trastuzumab therapy, suggests a meta-analysis that also confirmed such protection by dexrazoxane.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 14, 2022 Category: Cancer & Oncology Tags: Cardiology News Source Type: news